Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy
Ana I. Rojo(Biomedical Research Networking Center on Neurodegenerative Diseases), Antonio Cuadrado(Biomedical Research Networking Center on Neurodegenerative Diseases), Izaskun Buendía(Universidad Autónoma de Madrid), Manuela G. López(Hospital Universitario de La Princesa), Masayuki Yamamoto(Tohoku University), Ángel J. García‐Yagüe(Instituto de Investigaciones Biomédicas Sols-Morreale), Fred Van Leuven(KU Leuven), Marta Pajares(Instituto de Salud Carlos III)
Cited by 128
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
|Nature Communications|2016|1.8k
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
|Cancer Cell|2012|1.4k
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
|Nature Reviews Drug Discovery|2019|1.4k
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906